Mixed acinar‐neuroendocrine carcinoma with amphicrine features of the pancreas: Two rare cases with diffuse co‐expression of acinar and neuroendocrine markers

2021 ◽  
Author(s):  
Ashwin S. Akki ◽  
Xiuli Liu ◽  
William L. Clapp ◽  
Petr Starostik ◽  
Kimberly J. Newsom ◽  
...  
2019 ◽  
Vol 8 (2) ◽  
pp. LMT13 ◽  
Author(s):  
Dmitriy Sonkin ◽  
Anish Thomas ◽  
Beverly A Teicher

Until recently, small cell lung cancer (SCLC) was described as SCLC and SCLC variant, based upon cellular morphology and loss of neuroendocrine markers in the SCLC variant. However, based on recent research advances, driven in part by the increase in comprehensive genomic data, it has become clear that there are multiple SCLC subtypes including an ASCL1 and NEUROD1 low, YAP1 high (SCLC-Y) subtype enriched for WT RB1. Comparing morphological and other features of this SCLC subtype to neuroendocrine negative RB1, KEAP1, STK11 WT LCNEC raises a number of important questions with diagnostic and therapeutic implications.


2005 ◽  
Vol 11 ◽  
pp. 75-76
Author(s):  
Shirin Haddady ◽  
Alan Perry Farwell ◽  
Ashraf Khan

2013 ◽  
Vol 121 (03) ◽  
Author(s):  
CHM Jaspers ◽  
R Salbeck ◽  
C Kahl ◽  
V Hans ◽  
G Berding ◽  
...  

2005 ◽  
Vol 113 (S 1) ◽  
Author(s):  
H Biering ◽  
N Brenner ◽  
M Ventz ◽  
C Strasburger

Sign in / Sign up

Export Citation Format

Share Document